AgeX
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AgeX and buy or sell other stocks, ETFs, and their options commission-free!About AGE
AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547.
CEOMichael D. West
CEOMichael D. West
Employees9
Employees9
HeadquartersAlameda, California
HeadquartersAlameda, California
Founded2017
Founded2017
Employees9
Employees9
AGE Key Statistics
Market cap337.76M
Market cap337.76M
Price-Earnings ratio-1.38
Price-Earnings ratio-1.38
Dividend yield—
Dividend yield—
Average volume266.40K
Average volume266.40K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.00
52 Week high$1.00
52 Week low$0.31
52 Week low$0.31
Stock Snapshot
As of today, AgeX(AGE) shares are valued at $8.90. The company's market cap stands at 337.76M, with a P/E ratio of -1.38.
On 2025-12-27, AgeX(AGE) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for AgeX(AGE) stock has reached 0, versus its average volume of 266.4K.
Over the past 52 weeks, AgeX(AGE) stock has traded between a high of $1.00 and a low of $0.31.
Over the past 52 weeks, AgeX(AGE) stock has traded between a high of $1.00 and a low of $0.31.
People also own
Based on the portfolios of people who own AGE. This list is generated using Robinhood data, and it’s not a recommendation.